Stocklytics Platform
Asset logo for symbol NTRA
Natera
NTRA78
$165.76arrow_drop_down2.10%-$3.56
High Growth
Asset logo for symbol NTRA
NTRA78

$165.76

arrow_drop_down2.10%

Income Statement (NTRA)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
EBIT-$27.72M-$33.44M-$64.04M-$74.69M-$116.12M
EBITDA-$19.52M-$25.53M-$53.39M-$64.27M-$105.57M
gross Profit$271.74M$243.17M$208.60M$159.85M$120.99M
NET Income-$31.59M-$37.46M-$67.59M-$78.03M-$109.03M
total Revenue$439.75M$413.35M$367.74M$311.10M$268.30M

Balance Sheet (NTRA)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
cash Equivalents-----
net Debt-$417.11M-$359.19M-$374.02M-$200.10M-$237.36M
stockholders Equity$878.52M$836.52M$794.11M$765.32M$784.65M
total Assets$1.59B$1.51B$1.46B$1.45B$1.44B
total Debt$475.73M$437.60M$439.79M$441.99M$431.34M
total Liabilities$712.42M$680.46M$674.09M$691.79M$661.86M

Cash Flow (NTRA)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
financing Cash Flow$1.72M$11.04M$6.46M$6.84M$236.00M
free Cash Flow$35.47M-$7.68M$6.68M-$67.65M-$38.65M
investing Cash Flow-----
operating Cash Flow$51.78M$3.99M$27.00M-$58.12M-$29.55M

Natera (NTRA) Financials

Natera Inc. (NTRA) is a leading and innovative genetic testing company that provides advanced diagnostics to help patients and healthcare professionals make informed decisions. The company's financials reflect its strong market position and steady growth. The income statement shows Natera's revenues and expenses, with gross profit representing the difference between total revenue and the cost of goods sold. Net income from stockholders is the final result after deducting taxes and other expenses. Natera's total revenue has been steadily increasing, indicating the company's success in attracting customers and expanding its testing services. The balance sheet provides a snapshot of Natera's financial health, with total assets reflecting the company's investments and total liabilities representing its obligations. Natera's stockholders' equity reveals the company's net worth, while cash equivalents indicate its readily available cash resources. Net debt reveals Natera's overall debt situation, taking into account its cash reserves. The cash flow statement breaks down the sources and uses of cash, with operating cash flow reflecting Natera's core business activities. Financing cash flow represents the funds generated or used for debt and equity transactions, while investing cash flow shows the company's investment in assets or divestment of assets. Free cash flow is a measure of Natera's cash flow available for use after accounting for capital expenditures. The financials provide valuable insights into Natera's financial performance and position, demonstrating the company's success in the genetic testing market.
add Natera  to watchlist

Keep an eye on Natera

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Take Your Investments to a Whole New Level